FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/03/032371 [Registered on: 30/03/2021] Trial Registered Prospectively
Last Modified On: 08/03/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Other 
Public Title of Study   A clinical trial on Kaattu Vakai Pattai Chooranam in the management of Raththamoolam (Bleeding haemorrhoids) 
Scientific Title of Study   A prospective open labelled,Non-Randomized,Phase II,Clinical trial of "Kaattu Vakai Pattai Chooranam "in the management of "Raththamoolam"(Bleeding Haemorrhoids) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  N Saraswathi 
Designation  Pg scholar  
Affiliation  Government siddha medical college and hospital,Palayamkottai,Tirunelveli  
Address  PG Department of pothu maruthuvam,OP no 10, Government siddha medical college and hospital,Palayamkottai,Tirunelveli ,Tamilnadu

Tirunelveli
TAMIL NADU
627002
India 
Phone  8190076987  
Fax    
Email  saraswathin30051967@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrGSubash chandran 
Designation  Lecturer Grade II  
Affiliation  Government siddha medical college and hospital  
Address  Department of PothuMaruthuvam,Op.no.10 Government Siddha medical college and hospital,Palayamkottai,Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9443358271  
Fax    
Email  siddhadrgs21@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrAManoharan  
Designation  Professor and HOD  
Affiliation  Government siddha medical college and hospital,Palayamkottai,Tirunelveli  
Address  Head of the Department, Department of PothuMaruthuvam,Op.no.10 Government siddha medical college and hospital,Palayamkottai,Tirunelveli

Tirunelveli
TAMIL NADU
627002
India 
Phone  9443886700  
Fax    
Email  drmanoharan25@gmail.com  
 
Source of Monetary or Material Support  
OPD &IPD facilities and Central library of Government Siddha Medical College and Hospital, Palayamkottai, Thirunelveli. 
 
Primary Sponsor  
Name  Government siddha medical college and hospital  
Address  Government siddha medical college and hospital,Palayamkottai,Tirunelveli  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
N Saraswathi  Government Siddha Medical College and Hospital   PG Department of Pothu Maruthuvam ,OP no 10, Government Siddha Medical College and Hospital,Palayamkottai,Tirunelveli
Tirunelveli
TAMIL NADU 
8190076987

saraswathin30051967@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K640||First degree hemorrhoids,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Kaattu Vakai Pattai Chooranam  2g/Twice a day(orally)A/F with ghee for 45 days 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients who will be having classical symptoms of bleeding piles (1st degree internal haemorrhoids)i.e. constipation, bleeding per anus,itching in the perianal region.
Patients who are all willing to give blood samples at subsequent visit are involved in this study.
Patient willing to sign the informed consent starting that he/ she will conscientiously stick to the treatment during 45 days but can opt of the trail of his/her own conscious discretion.  
 
ExclusionCriteria 
Details  Patients of age below 18 years and above 60 years.
Patients having 2nd ,3rd degree internal haemorrhoids.
Pregnancy.
Fissure in ano.
External haemorrhoids.
Fistula in ano.
Diabetes mellitus.
Hypertension.
Rectal cancer.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Outcome of the treatment is mainly assessed by reduction in clinical symptoms and by comparing the following parameters before and after treatment.
Bleeding per rectum.
Proctoscopy.  
45 days 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate Physico Chemical, PhytoChemical,Bio Chemical analysis.
To evaluate safety profile for acute and sub-acute toxicity of trial drug Kaattu Vakai Pattai Chooranam
To determine about Antimicrobial activities in different Solvents.
To evaluate additional effects &Siddha parameters, Envagaithervukal in Raththa Moolam
To evaluate the efficacy of Kaattu Vakai Pattai Chooranam on Raththamoolam by the Biostatistical analysis. 
45 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/04/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is a prospective open labelled non randomized phase II clinical study on KAATTU VAKAI PATTAI CHOORANAM in the management of RATHTHAMOOLAM (BLEEDING HAEMORRHOIDS).The trial drug will be administered at the dose of 2g/Twice a day orally A/F for 45 days along with ghee as adjuvent in 45 patients. The trial period of 12 months will be carrying out in Government siddha medical college and hospital,Palayamkottai,Tirunelveli. The primary outcome will be evaluation of therapeutic efficacy of trial drug KAATTU VAKAI PATTAI CHOORANAM. The secondary outcome will be the evaluation of siddha diagnostic parameters, assessment of safety profile of trial drug ,assessment of pharmacological and biochemical parameters of trial drug.In case of any adverse event (AE)is noticed and it will be referred to pharmacovigilance department of SCRI.Further management of patient will be given in OPD facility. 
Close